Current Neuro-Oncology
Volume
4 Number 2
28 February 2002
Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 2, 28 February
Fahlbusch R, Schott W.
Pterional
surgery of meningiomas of the tuberculum sellae and planum
sphenoidale: surgical results with special consideration of
ophthalmological and endocrinological outcomes.
J
Neurosurg. 2002 Feb;96(2):235-43∟.
doi: 10.3171/jns.2002.96.2.0235∟.
PMID: 11838796∟.
Observational study. ˍ
Fontaine D, Capelle L, Duffau
H.
Somatotopy
of the supplementary motor area: evidence from correlation of the
extent of surgical resection with the clinical patterns of
deficit.
Neurosurgery.
2002 Feb;50(2):297-303∟.
doi: 10.1097/00006123-200202000-00011∟.
PMID: 11844264∟.
Observational study. ˍ
Gerlach R, Kieslich M, van de Nes
J, Galow W, Seifert V.
Supratentorial
leptomeningeal metastasis of a medulloblastoma without cerebellar
tumor recurrence.
Acta
Neurochir (Wien). 2002 Feb;144(2):201-4∟.
doi: 10.1007/s007010200025∟.
PMID: 11862522∟.
Case report. ˍ
Pompili A, Caperle M, Pace A,
Ramazzotti V, Raus L, Jandolo B, Occhipinti E.
Quality-of-life
assessment in patients who had been surgically treated for
cerebellar pilocytic astrocytoma in childhood.
J
Neurosurg. 2002 Feb;96(2):229-34∟.
doi: 10.3171/jns.2002.96.2.0229∟.
PMID: 11838795∟.
Observational study. ˍ
Prayson RA, Chowdhary S, Woodhouse
S, Hanson M, Nair S.
Collision
of a syncytial meningioma and malignant astrocytoma.
Ann
Diagn Pathol. 2002 Feb;6(1):44-8∟.
doi: 10.1053/adpa.2002.30612∟.
PMID: 11842378∟.
Case report. ˍ
Taylor SA, Rankin C, Townsend JJ, Craig JB, Vance RB, Solank DL,
Brown TD, Jaeckle K; Southwest Oncology Group.
Phase
II trial of amonafide in central
nervous system tumors: a Southwest
Oncology Group study.
Invest New Drugs. 2002
Feb;20(1):113-5∟.
doi: 10.1023/a:1014488922368∟.
PMID: 12003186∟.
Interventional study. ˍ
Viñolas N, Gil M, Verger E,
Villá S, Pujol T, Ceral L, García M, Graus
F.
Pre-irradiation
semi-intensive chemotherapy with carboplatin and cyclophosphamide
in malignant glioma: a phase II study.
Anticancer
Drugs. 2002 Feb;13(2):163-7∟.
doi: 10.1097/00001813-200202000-00008∟.
PMID: 11901309∟.
Interventional study. ˍ
Voulgaris S, Partheni M, Karamouzis
M, Dimopoulos P, Papadakis N, Kalofonos HP.
Intratumoral
doxorubicin in patients with malignant brain gliomas.
Am
J Clin Oncol. 2002 Feb;25(1):60-4∟.
doi: 10.1097/00000421-200202000-00013∟.
PMID: 11823699∟.
Observational study. ˍ
Karim AB, Afra D, Cornu P, Bleehan
N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van
Glabbeke M.
Randomized
trial on the efficacy of radiotherapy for cerebral low-grade
glioma in the adult: European Organization for Research and
Treatment of Cancer Study 22845 with the Medical Research Council
study BRO4: an interim analysis.
Int
J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24∟.
doi: 10.1016/s0360-3016(01)02692-x∟.
PMID: 11872276∟.
Interventional study. ˍ
Merchant TE, Zhu Y, Thompson SJ,
Sontag MR, Heideman RL, Kun LE.
Preliminary
results from a Phase II trail of conformal radiation therapy for
pediatric patients with localised low-grade astrocytoma and
ependymoma.
Int
J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):325-32∟.
doi: 10.1016/s0360-3016(01)01807-7∟.
PMID: 11872277∟.
Interventional study. ˍ
Pollack IF, Finkelstein SD, Woods
J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay
JL, Sposto R; Children's Cancer Group.
Expression
of p53 and prognosis in children with malignant gliomas.
N
Engl J Med. 2002 Feb 7;346(6):420-7∟.
doi: 10.1056/NEJMoa012224∟.
PMID: 11832530∟.
Observational study. ˍ
Huang E, Teh BS, Strother DR, Davis
QG, Chiu JK, Lu HH, Carpenter LS, Mai WY, Chintagumpala MM, South
M, Grant WH 3rd, Butler EB, Woo SY.
Intensity-modulated
radiation therapy for pediatric medulloblastoma: early report on
the reduction of ototoxicity.
Int
J Radiat Oncol Biol Phys. 2002 Feb 8;52(3):599-605∟.
doi: 10.1016/s0360-3016(01)02641-4∟.
PMID: 11849779∟.
Observational study. ˍ
*
Grana C, Chinol M, Robertson C,
Mazzetta C, Bartolomei M, De Cicco C, Fiorenza M, Gatti M,
Caliceti P, Paganelli G.
Pretargeted
adjuvant radioimmunotherapy with yttrium-90-biotin in malignant
glioma patients: a pilot study.
Br
J Cancer. 2002 Feb 8;86(2):207-12∟. doi:
10.1038/sj.bjc.6600047∟. PMID: 11870507∟.
Interventional study. ˍ
Chakravarti A, Noll E, Black PM,
Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler
JS.
Quantitatively
determined survivin expression levels are of prognostic value in
human gliomas.
J
Clin Oncol. 2002 Feb 15;20(4):1063-8∟.
doi: 10.1200/JCO.2002.20.4.1063∟.
PMID: 11844831∟.
Observational study. ˍ